Regulatory News In Brief
This article was originally published in The Tan Sheet
FDA distinguishes supplements from medical foods; super fruits are not drugs, FA explains; Sunland resumes production; Bayer voluntarily nixes Alka-Seltzer claims; FDA cites inflammation as drug claim; three Florida supplement makers warned for drug claims; and FDA warns Michigan e-commerce firm on claims.
You may also be interested in...
In a series of interviews, food safety experts weigh in on why the food and nutritional products industry still has work to do with the Food Safety Modernization Act not yet implemented, as illustrated by the recent salmonella contamination of peanut ingredients from Sunland Inc.
Bayer has assured the National Advertising Division of the Council of Better Business Bureaus it immediately discontinued certain parity claims made for Alka-Seltzer Plus Cold Medicine after NAD decided the modified advertising still was problematic.
Pink Sheet Podcast: COVID Vaccine In Adolescents, CMS Drug Pricing Moves, Standard Care In Clinical Trials
Pink Sheet reporters and editors discuss the US FDA decision to lower the eligibility age for the Pfizer/BioNTech COVID-19 vaccine, CMS drug pricing project plans, and mid-stream standard of care changes in drug development.